SOURCE: Medivation

Medivation

November 06, 2015 16:10 ET

Medivation Announces Participation at Upcoming Investor Conference

SAN FRANCISCO, CA--(Marketwired - Nov 6, 2015) - Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:

  • David Hung, M.D., president and chief executive officer, and Rick Bierly, chief financial officer, will participate in a fireside chat at the Jefferies Autumn 2015 Global Healthcare Conference on Thursday, November 19, at 8:00am GMT at The May Fair Hotel, London

Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm. A replay of the webcast will be available on the Company's website for 30 days following the live event.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the development and commercialization of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at http://www.medivation.com

Contact Information

  • Contacts:
    Anne Bowdidge
    Sr. Director, Investor Relations
    (650) 218-6900